Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
100%
Sphingolipid
100%
Lipopolysaccharide
83%
Mitogen Activated Protein Kinase P38
50%
Sphingomyelin Phosphodiesterase Inhibitor
50%
Mouse
33%
Adult Respiratory Distress Syndrome
33%
Sphingosine Kinase Inhibitor
33%
Survival Rate
16%
Sphingosine 1 Phosphate
16%
Mitogen Activated Protein Kinase P38 Inhibitor
16%
Ceramide
16%
SB 203580
16%
Chlorpromazine
16%
Lipopolysaccharide-Induced Acute Lung Injury
16%
Pneumonia
16%
Sphingomyelin Phosphodiesterase
16%
Biochemistry, Genetics and Molecular Biology
Lipopolysaccharide
100%
Sphingolipid
100%
Neutrophil Granulocyte
83%
P38 Mitogen-Activated Protein Kinases
66%
Acid Sphingomyelinase
66%
Sphingomyelin Phosphodiesterase
66%
Mouse
33%
Sphingosine Kinase
33%
Survival Rate
16%
Ceramide
16%
Sphingosine-1-Phosphate
16%
Chlorpromazine
16%
Immunology and Microbiology
Neutrophil Granulocyte
100%
Neutrophil
100%
Mitogen
80%
Mouse
40%
Pulmonary Inflammation
20%
Survival Rate
20%
Chlorpromazine
20%